Global Immunotherapy Drugs Market By Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases), By End User (Hospitals, Clinics), By Type of Drug (Monoclonal Antibodies, Adult Vaccines, Preventive Vaccines, Therapeutic Vaccines, Checkpoint Inhibitors, Interferons Alpha & Beta, Interleukins), By Geographic Scope & Forecast
Report Highlights
Immunotherapy Drugs Market Size And Forecast
Immunotherapy Drugs Market was valued at USD 142.87 Billion in 2019 and is projected to reach USD 321.98 Billion by 2027, growing at a CAGR of 10.7% from 2020 to 2027.
Immunotherapy Drugs Market Overview
The onset of cancer diseases is one of the significant reasons for the rise of Immunotherapy Drugs in the market. The National Cancer Institute states that in 2018, around 1,735, 350 new cancer cases were diagnosed in the United States. The new cancer cases are 439.2 per 100,000 men and women per year. The increased preference for monoclonal antibodies and biosimilars is the crucial factor responsible for the surge in market growth. The monoclonal antibodies are useful since the research scientists can design antibodies that can specifically target a particular cancer antigen. Various copies of the antibodies can be prepared by in vitro techniques in the laboratory. Biosimilars are of vital importance to treat cancer. Biosimilars are not generic drugs. The biologic drugs are quite prominent in structure and complicated to make than chemical medications. It is impossible to prepare an original drug copy; hence a biosimilar or a highly similar copy is made. The biosimilar must follow the FDAs strict guidelines and regulations and continuous evaluation to guarantee safety and quality.
Immunotherapy Drugs Market: Segmentation Analysis
The Global Immunotherapy Drugs Market is segmented based on Product, End-Use, Therapy Area, and Geography.
Immunotherapy Drugs Market Competitive Landscape
The Global Immunotherapy Drugs Market study report will provide a valuable insight with an emphasis on the global market. The major players in the market are F. Hoffmann-La Roche Ltd. (UK), Pfizer Inc. (US), Merck & Co (US), Novartis International AG (UK), Johnson & Johnson (US), Sanofi (France), GlaxoSmithKline Plc (UK), Amgen Inc. (US), AbbVie Inc. (US), Boehringer Ingelheim (Germany), AstraZeneca (UK), and Immatics Biotechnologies (Germany), BioNTech SE, Genmab, Gilead Sciences, NBE Therapeutics, Teva Pharmaceuticals, Bayer, and Bristol-Myers Squibb. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.